However, Yang et al. confirmed high expression of CXCR2 in higher grades of glioma tissues and reported positive correlation with the degree of malignancy and recurrence and also demonstrated that pharmacological blocking of CXCR2 significantly reduced the migration of glioma cells [28]. This evidence concerns the gene CXCR2 and central nervous system cancer.